ADEN — ADENTRA Income Statement
0.000.00%
- CA$814.49m
- CA$1.59bn
- $2.25bn
Annual income statement for ADENTRA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,616 | 2,580 | 2,239 | 2,184 | 2,249 |
| Cost of Revenue | |||||
| Gross Profit | 373 | 557 | 466 | 474 | 488 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,468 | 2,383 | 2,147 | 2,087 | 2,146 |
| Operating Profit | 148 | 197 | 92.3 | 96.9 | 103 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 138 | 163 | 42.9 | 55.3 | 66 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 103 | 129 | 36 | 46.5 | 68.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 103 | 129 | 36 | 46.5 | 68.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 103 | 129 | 36 | 46.5 | 68.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.91 | 5.48 | 1.59 | 1.92 | 2.71 |
| Dividends per Share |